Harris Health System - Smith Clinic

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Triple-negative breast cancer3 trials
• Metastatic breast cancer2 trials
• Bladder cancer1 trial
• Chronic myeloid leukaemia1 trial
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 25 trials
• Phase 32 trials
• Phase 11 trial
• Phase 1/21 trial

Status

• Active, not recruiting4 trials
• Recruiting3 trials
• Completed2 trials
• Terminated1 trial

Lead sponsor

• Baylor College of Medicine4 trials
• Baylor Breast Care Center2 trials
• Anthony Costales, MD1 trial
• LeonaBio1 trial
• Mothaffar Rimawi1 trial
• and 1 more

Running trials

• Recruiting

  Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  NCT05696626· Phase 3· LeonaBio· Source

  Contact: Ahmed Elkhanany

• Recruiting

  Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

  NCT05020860· Phase 2· Baylor Breast Care Center· Source

  Contact: Maria Rodriguez

• Recruiting

  Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

  NCT04586959· Anthony Costales, MD· Source

  Contact: Anthony Costales, MD

• Active, not recruiting

  Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

  NCT04626024· Phase 2· Baylor College of Medicine· Source

• Active, not recruiting

  Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer

  NCT03324425· Phase 2· Baylor Breast Care Center· Source

• Active, not recruiting

  Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

  NCT03281954· Phase 3· NSABP Foundation Inc· Source

• Active, not recruiting

  Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer

  NCT02547987· Phase 2· Mothaffar Rimawi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Endometrial cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Terminated

  A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer

  NCT05567835· Phase 2· Baylor College of Medicine· Source

• Completed

  TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer

  NCT03192462· Phase 1/2· Baylor College of Medicine· Source

• Completed

  Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer

  NCT02885974· Phase 1· Baylor College of Medicine· Source